VSIG4 and breast cancer: Although VSIG4 expression is restricted in tissue-resident macrophages at a steady state, several studies have reported an upregulation of VSIG4 expression in lung cancer (93), breast cancer (94), ovarian cancer (95), and multiple myeloma (MM) (96).